Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei
ConclusionsPET-PCI can reflect histopathologic features and appears useful for predicting recurrence in patients with PMP.Key Points•Peritoneal cancer index using 18F-FDG-PET/CT (PET-PCI) has great potential for predicting progression-free survival in patients with pseudomyxoma peritonei.•PET-PCI provides higher prognostic performance than maximum standardized uptake value (SUVmax).•PET-PCI shows high correlation with histopathologic grade of pseudomyxoma peritonei.
Source: European Radiology - Category: Radiology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Liver | Peritoneal Cancer | Radiology | Study | Urology & Nephrology